These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27438969)

  • 1. Oxidized LDL: As a risk factor for cardiovascular disease in renal transplantation.
    Soltani A; Argani H; Rahimipour H; Soleimani F; Rahimi F; Kazerouni F
    J Bras Nefrol; 2016 Jun; 38(2):147-52. PubMed ID: 27438969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo oxidized low-density lipoprotein (ox-LDL) aopp and tas after kidney transplantation: a prospective, randomized one year study comparing cyclosporine A and tacrolimus based regiments.
    Zadrazil J; Horak P; Strebl P; Krejci K; Kajabova M; Schneiderka P; Zapletalova J; Galandakova A; Vostalova J; Vaverkova H
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):14-20. PubMed ID: 22580856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Serum Oxidized Low-Density Lipoprotein in Renal Transplant Recipients and Hemodialysis Patients and Relation With Involved Variables.
    Soltani A; Argani H; Soleimani F; Rahimipour H; Akbarzadeh-Baghban A; Azizi T; Kazerouni F; Farshchian F
    Exp Clin Transplant; 2015 Dec; 13(6):524-8. PubMed ID: 26086712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.
    Bergesio F; Monzani G; Ciuti R; Cirami C; Martinelli F; Salvadori M; Tosi PL
    Nephron; 2001 Feb; 87(2):127-33. PubMed ID: 11244306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population.
    Gottlieb MG; Schwanke CH; Santos AF; Jobim PF; Müssel DP; da Cruz IB
    Genet Mol Res; 2005 Dec; 4(4):691-703. PubMed ID: 16475114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study.
    Zuliani G; Morieri ML; Volpato S; Vigna GB; Bosi C; Maggio M; Cherubini A; Bandinelli S; Guralnik JM; Ferrucci L
    Atherosclerosis; 2013 Jan; 226(1):201-7. PubMed ID: 23141584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women.
    Lapointe A; Couillard C; Piché ME; Weisnagel SJ; Bergeron J; Nadeau A; Lemieux S
    Atherosclerosis; 2007 Apr; 191(2):362-8. PubMed ID: 16677652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus.
    Nakhjavani M; Asgharani F; Khalilzadeh O; Esteghamati A; Ghaneei A; Morteza A; Anvari M
    Am J Med Sci; 2011 Feb; 341(2):92-5. PubMed ID: 20890173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.
    Jialal I; Devaraj S; Adams-Huet B; Chen X; Kaur H
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1844-50. PubMed ID: 22872691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein.
    Schroder H; Marrugat J; Fíto M; Weinbrenner T; Covas MI
    Free Radic Biol Med; 2006 Apr; 40(8):1474-81. PubMed ID: 16631537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
    Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
    Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
    Collado S; Coll E; Deulofeu R; Guerrero L; Pons M; Cruzado JM; de la Torre B; Vera M; Azqueta M; Nicolau C; Cases A
    Nefrologia; 2010; 30(3):342-8. PubMed ID: 20514101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients.
    Kandoussi AM; Glowacki F; Duriez P; Tacquet A; Fruchart JC; Noël C
    Nephron; 2001 Nov; 89(3):303-8. PubMed ID: 11598394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
    Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
    Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum small-dense LDL abnormalities in chronic renal disease patients.
    Chu M; Wang AY; Chan IH; Chui SH; Lam CW
    Br J Biomed Sci; 2012; 69(3):99-102. PubMed ID: 23057155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.